Cite

HARVARD Citation

    Simonini, G. et al. (n.d.). Clinical and transcriptional response to the long‐acting interleukin‐1 blocker canakinumab in Blau syndrome–related uveitis. Arthritis and rheumatism. 65 (2), pp. 513-518. [Online]. 
  
Back to record